The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines

International Journal of Developmental Biology

Volumn 48, Issue 5-6, 2004, Pages 519-527

  Opdenakker, Ghislain ^a   Van Damme, Jo ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Chemokine; Chemokine receptor; Gene transfer

Indexed keywords

ALPHA CHEMOKINE; ARGININE; CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CYSTEINE; EOTAXIN; GLUTAMIC ACID; INTERLEUKIN 8; LEUCINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEINASE; RANTES; TUMOR ANTIGEN; UNINDEXED DRUG;

ANGIOGENESIS; BREAST CARCINOMA; CANCER IMMUNOLOGY; CANCER INVASION; COLON CARCINOMA; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FLUORESCENCE ACTIVATED CELL SORTER; HELPER CELL; HUMAN; LEUKOCYTE; LUNG CANCER; METASTASIS; NATURAL KILLER CELL; NONHUMAN; OVARY CARCINOMA; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; REVIEW; THYROID CARCINOMA; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ANTIGENS, NEOPLASM; CHEMOKINES; CHROMOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; HUMANS; LIGANDS; MODELS, GENETIC; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 5444236856     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.041796go     Document Type: Review

References (89)

1. ABDOLLAHI, T., ROBERTSON, N.M., ABDOLLAHI, A. and LITWACK, G. (2003). Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3. Cancer Res. 63:4521-4526.
2. ADDISON, C.L., ARENBERG, D.A., MORRIS, S.B., XUE, Y.Y., BURDICK, M.D., MULLIGAN, M.S., IANNETTONI, M.D. and STRIETER, R.M. (2000). The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis. Hum. Gene Ther. 11:247-261.
3. AIUTI, A., WEBB, I.J., BLEUL, C., SPRINGER, T. and GUTIERREZ-RAMOS, J.C. (1997). The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 185:111-120.
4. ARENBERG, D.A., KUNKEL, S.L., POLVERINI, P.J., MORRIS, S.B., BURDICK, M.D., GLASS, M.C., TAUB, D.T., IANNETTONI, M.D., WHYTE, R.I. and STRIETER, R.M. (1996). Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184:981-992.
5. BACHELDER, R.E., WENDT, M.A. and MERCURIO, A.M. (2002). Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 62:7203-7206.
6. BALKWILL, F. and MANTOVANI, A. (2001). Inflammation and cancer: back to Virchow? Lancet. 357:539-545.
7. BARBERO, S., BONAVIA, R., BAJETTO, A., PORCILE, C., PIRANI, P., RAVETTI, J.L., ZONA, G.L., SPAZIANTE, R., FLORIO, T. and SCHETTINI, G. (2003). Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res. 63:1969-1974.
8. BELPERIO, J.A., KEANE, M.P., ARENBERG, D.A., ADDISON, C.L., EHLERT, J.E., BURDICK, M.D. and STRIETER, R.M. (2000). CXC chemokines in angiogenesis. J. Leukoc. Biol. 68:1-8.
9. BENDRE, M.S., GADDY-KURTEN, D., MON-FOOTE, T., AKEL, N.S., SKINNER, R.A., NICHOLAS, R.W. and SUVA, L.J. (2002). Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res. 62:5571-5579.
10. BILLIAU, A., EDY, V.G., HEREMANS, H., VAN DAMME, J., DESMYTER, J., GEORGIADES, J.A. and DE SOMER, P. (1977). Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother. 12:11-15.
11. BIRAGYN, A., TANI, K., GRIMM, M.C., WEEKS, S. and KWAK, L.W. (1999). Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. Nat. Biotechnol. 17:253-258.
12. BREW, R., ERIKSON, U.S., WEST, D.C., KINSELLA, A.R., SLAVIN, J. and CHRISTMAS, S.E. (2000). Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine. 12:78-85.
13. CAO, Z., BAGULEY, B.C. and CHING, L.M. (2001). Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Cancer Res. 61:1517-1521.
14. CARDONES, A.R., MURAKAMI, T. and HWANG, S.T. (2003). CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res. 63:6751-6757.
15. CHAN, C.C., SHEN, D., HACKETT, J.J., BUGGAGE, R.R. and TUAILLON, N. (2003). Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. Ophthalmology. 110:421-426.
16. CHEN, J.J., YAO, P.L., YUAN, A., HONG, T.M., SHUN, C.T., KUO, M.L., LEE, Y.C. and YANG, P.C. (2003). Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin. Cancer Res. 9:729-737.
17. CHOI, S.J., OBA, Y., GAZITT, Y., ALSINA, M., CRUZ, J., ANDERSON, J. and ROODMAN, G.D. (2001). Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J. Clin. Invest. 108:1833-1841.
18. COUSSENS, L.M., TINKLE, C.L., HANAHAN, D. and WERB, Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 103:481-490.
19. COUSSENS, L.M. and WERB, Z. (2002). Inflammation and cancer. Nature. 420:860-867. Review.
20. DAVIDSON, B., REICH, R., KOPOLOVIC, J., BERNER, A., NESLAND, J.M., KRISTENSEN, G.B., TROPE, C.G., BRYNE, M., RISBERG, B., VAN DE PUTTE, G. and GOLDBERG, I. (2002). Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions. Clin. Exp. Metastasis. 19:135-144.
21. DELLACASAGRANDE, J., SCHREURS, O.J., HOFGAARD, P.O., OMHOLT, H., STEINSVOLL, S., SCHENCK, K., BOGEN, B. and DEMBIC, Z. (2003). Liver metastasis of cancer facilitated by chemokine receptor CCR6. Scand. J. Immunol. 57:534-544.
22. FOLKMAN, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1:27-31.
23. FUJISAWA, N., HAYASHI, S. and MILLER, E.J. (1999). A synthetic peptide inhibitor for alpha-chemokines inhibits the tumour growth and pulmonary metastasis of human melanoma cells in nude mice. Melanoma Res. 9:105-114.
24. FUJISAWA, N., SAKAO, Y., HAYASHI, S., HADDEN, W.A. 3RD, HARMON, C.L and MILLER, E.J. (2000). alpha-Chemokine growth factors for adenocarcinomas; a synthetic peptide inhibitor for alpha-chemokines inhibits the growth of adenocarcinoma cell lines. J. Cancer Res. Clin. Oncol. 126:19-26.
25. GALFFY, G., MOHAMMED, K.A., DOWLING, P.A., NASREEN, N., WARD, M.J. and ANTONY, V.B. (1999). Interleukin 8: an autocrine growth factor for malignant mesothelioma. Cancer Res. 59:367-371.
26. GALFFY, G., MOHAMMED, K.A., NASREEN, N., WARD, M.J. and ANTONY, V.B. (1999). Inhibition of interleukin-8 reduces human malignant pleural mesothelioma propagation in nude mouse model. Oncol. Res. 11:187-194.
27. GAO, J.Q., TSUDA, Y., KATAYAMA, K., NAKAYAMA, T., HATANAKA, Y., TANI, Y., MIZUGUCHI, H., HAYAKAWA, T., YOSHIE, O., TSUTSUMI, Y., MAYUMI, T. and NAKAGAWA, S. (2003). Antitumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector. Cancer Res. 63:4420-4425.
28. GIOVARELLI, M., CAPPELLO, P., FORNI, G., SALCEDO, T., MOORE, P.A., LEFLEUR, D.W., NARDELLI, B., CARLO, E.D., LOLLINI, P.L., RUBEN, S., ULLRICH, S., GAROTTA, G. and MUSIANI, P. (2000). Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. J. Immunol. 164:3200-3206.
29. GUO, J., ZHANG, M., WANG, B., YUAN, Z., GUO, Z., CHEN, T., YU, Y., QIN, Z. and CAO, X. (2003). Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells. Int. J. Cancer. 103:212-220.
30. HAGHNEGAHDAR, H., DU, J., WANG, D., STRIETER, R.M., BURDICK, M.D., NANNEY, L.B., CARDWELL, N., LUAN, J., SHATTUCK-BRANDT, R. and RICHMOND, A. (2000). The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J. Leukoc. Biol. 67:53-62.
31. HARAGUCHI, M., KOMUTA, K., AKASHI, A., MATSUZAKI, S., FURUI, J. and KANEMATSU, T. (2002). Elevated IL-8 levels in the drainage vein of resectable Dukes' C colorectal cancer indicate high risk for developing hepatic metastasis. Oncol. Rep. 9:159-165.
32. HELBIG, G., CHRISTOPHERSON, K.W. 2ND, BHAT-NAKSHATRI, P., KUMAR, S., KISHIMOTO, H., MILLER, K.D., BROXMEYER, H.E. and NAKSHATRI, H. (2003). NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 278:21631-21638.
33. HU, J.Y., LI, G.C., WANG, W.M., ZHU, J.G., LI, Y.F., ZHOU, G.H. and SUN, Q.B. (2002). Transfection of colorectal cancer cells with chemokine MCP-3 (monocyte chemotactic protein-3) gene retards tumor growth and inhibits tumor metastasis. World J. Gastroenterol. 8:1067-1072.
34. HUANG, R., LIN, Y., WANG, C.C., GANG, J., LIN, B., SHI, Q., BOYNTON, A., BURKE, J. and HUANG, R.P. (2002). Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res. 62:2806-2812.
35. INOUE, K., WOOD, C.G., SLATON, J.W., KARASHIMA, T., SWEENEY, P. and DINNEY, C.P. (2001). Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8. Oncol. Rep. 8:955-964.
36. JUAREZ, J., BRADSTOCK, K.F., GOTTLIEB, D.J. and BENDALL, L.J. (2003). Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia. 17:1294-1300.
37. KATO, M., KITAYAMA, J., KAZAMA, S. and NAGAWA H. (2003). Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res. 5:R144-150.
38. KIJIMA, T., MAULIK, G., MA, P.C., TIBALDI, E.V., TURNER, R.E., ROLLINS, B., SATTLER, M., JOHNSON, B.E. and SALGIA, R. (2002). Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res. 62:6304-6311.
39. KITADAI, Y., HARUMA, K., SUMII, K., YAMAMOTO, S., UE, T., YOKOZAKI, H., YASUI, W., OHMOTO, Y., KAJIYAMA, G., FIDLER, I.J. and TAHARA, E. (1998). Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am. J. Pathol. 152:93-100.
40. KLEINE-LOWINSKI, K., RHEINWALD, J.G., FICHOROVA, R.N., ANDERSON, D.J., BASILE, J., MUNGER, K., DALY, C.M., ROSL, F. and ROLLINS, B.J. (2003). Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells. Int. J. Cancer. 107:407-415.
41. KOCH, A.E., POLVERINI, P.J., KUNKEL, S.L., HARLOW, L.A., DIPIETRO, L.A., ELNER, V.M., ELNER, S.G. and STRIETER, R.M. (1992). Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 258:1798-1801.
42. KUNZ, M., HARTMANN, A., FLORY, E., TOKSOY, A., KOCZAN, D., THIESEN, H.J., MUKAIDA, N., NEUMANN, M., RAPP, U.R., BROCKER, E.B. and GILLITZER, R. (1999) Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am. J. Pathol. 155:753-763.
43. KURT, R.A., BAHER, A., WISNER, K.P., TACKITT, S. and URBA, W.J. (2001). Chemokine receptor desensitization in tumor-bearing mice. Cell. Immunol. 207:81-8.
44. LEE, J.M., MERRITT, R.E., MAHTABIFARD, A., YAMADA, R., KIKUCHI, T., CRYSTAL, R.G. and KORST, R.J. (2003). Intratumoral expression of macrophage-derived chemokine induces CD4+ T cell-independent antitumor immunity in mice. J. Immunother. 26:117-129.
45. MAIONE, T.E., GRAY, G.S., PETRO, J., HUNT, A.J., DONNER, A.L., BAUER, S.I, CARSON, H.F. and SHARPE, R.J. (1990). Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science. 247:77-79.
46. MAREEL, M. and LEROY, A. (2003). Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 83:337-376.
47. MASAMUNE, A., YOSHIDA, M., SAKAI, Y. and SHIMOSEGAWA, T. (2001). Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells. J. Pharmacol. Exp. Ther. 298:485-492.
48. MASOOD, R., CAI, J., TULPULE, A., ZHENG, T., HAMILTON, A., SHARMA, S., ESPINA, B.M., SMITH, D.L. and GILL, P.S. (2001). Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma. Clin. Cancer Res. 7:2693-2702.
49. MELANI, C., PUPA, S.M., STOPPACCIARO, A., MENARD, S., COLNAGHI, M.I., PARMIANI, G. and COLOMBO, M.P. (1995). An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines. Int J Cancer. 62:572-578.
50. MENTEN, P., SACCANI, A., DILLEN, C., WUYTS, A., STRUYF, S., PROOST, P., MANTOVANI, A., WANG, J.M. and VAN DAMME, J. (2002). Role of the autocrine chemokines MIP-1alpha and MIP-1beta in the metastatic behavior of murine T cell lymphoma. J. Leukoc. Biol. 72:780-789.
51. MORAN, C.J., ARENBERG, D.A., HUANG, C.C., GIORDANO, T.J., THOMAS, D.G., MISEK, D.E., CHEN, G., IANNETTONI, M.D., ORRINGER, M.B., HANASH, S. and BEER, D.G. (2002). RANTES expression is a predictor of survival in stage I lung adenocarcinoma. Clin. Cancer Res. 8:3803-3812.
52. MULLER, A., HOMEY, B., SOTO, H., GE, N., CATRON, D., BUCHANAN, M.E., MCCLANAHAN, T., MURPHY, E., YUAN, W., WAGNER, S.N., BARRERA, J.L., MOHAR, A., VERASTEGUI, E. and ZLOTNIK, A. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50-56.
53. MULLER, R., ZHENG, M. and MROWIETZ, U. (1997). Significant reduction of human monocyte chemotactic response to monocyte-chemotactic protein 1 in patients with primary and metastatic malignant melanoma. Exp. Dermatol. 6:81-86.
54. MURAKAMI, T., MAKI, W., CARDONES, A.R., FANG, H., TUN KYI, A., NESTLE, F.O. and HWANG, S.T. (2002). Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 62:7328-7334.
55. NAGAI, M. and MASUZAWA, T. (2001). Vaccination with MCP-1 cDNA transfectant on human malignant glioma in nude mice induces migration of monocytes and NK cells to the tumor. Int. Immunopharmacol. 1:657-664.
56. NARVAIZA, I., MAZZOLINI, G., BARAJAS, M., DUARTE, M., ZARATIEGUI, M., QIAN, C., MELERO, I. and PRIETO, J. (2000). Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy. J. Immunol. 164:3112-3122.
57. NESBIT, M., SCHAIDER, H., MILLER, T.H. and HERLYN, M. (2001). Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J. Immunol. 166:6483-6490.
58. NOMURA, T., HASEGAWA, H., KOHNO, M., SASAKI, M. and FUJITA, S. (2001). Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes. Int. J. Cancer. 91:597-606.
59. NURNBERG, W., TOBIAS, D., OTTO, F., HENZ, B.M. and SCHADENDORF, D. (1999). Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma. J. Pathol. 189:546-551.
60. OHSHIMA, K., SUEFUJI, H., KARUBE, K., HAMASAKI, M., HATANO, B., TUTIYA, T., YAMAGUCHI, T., SUZUKI, K., SUZUMIYA, J. and KIKUCHI, M. (2003). Expression of chemokine receptor CXCR3 and its ligand, mig, in gastric and thyroid marginal zone lymphomas. Possible migration and autocrine mechanism. Leuk. Lymphoma. 44:329-336.
61. OPDENAKKER, G. and VAN DAMME, J. (1992). Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine 4:251-258.
62. OPDENAKKER, G. and VAN DAMME, J. (1992). Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol Today 13:463-464.
63. OPDENAKKER, G. and VAN DAMME, J. (1999). Novel monocyte chemoattractants in cancer. In: Chemokines and Cancer (Editor. B. Rollins). Humana Press Inc., Totawa, New Jersey, USA, pp. 51-69.
64. PAUL, S., REGULIER, E., POITEVIN, Y., HORMANN, H. and ACRES, R.B. (2002). The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer. Cancer Immunol. Immunother. 51:645-654.
65. PERTL, U., LUSTER, A.D., VARKI, N.M., HOMANN, D., GAEDICKE, G., REISFELD, R.A. and LODE, H.N. (2001). IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. J. Immunol. 166:6944-6951.
66. POSZEPCZYNSKA, E., MARTINVALET, D., BOULOC, A., ECHCHAKIR, H., WECHSLER, J., BECHEREL, P.A., BOUMSELL, L., BENSUSSAN, A. and BAGOT, M. (2001). Erythrodermic cutaneous T-cell lymphoma with disseminated pustulosis. Production of high levels of interleukin-8 by tumour cells. Br. J. Dermatol. 144:1073-1079.
67. PROOST, P., DEWOLF-PEETERS, C., CONINGS, R., OPDENAKKER, G., BILLIAU, A. and VAN DAMME, J. (1993). Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J. Immunol. 150:1000-1010.
68. PROOST, P., SCHUTYSER, E., MENTEN, P., STRUYF, S., WUYTS, A., OPDENAKKER, G., DETHEUX, M., PARMENTIER, M., DURINX, C., LAMBEIR, A.M., NEYTS, J., LIEKENS, S., MAUDGAL, P.C., BILLIAU, A. and VAN DAMME, J. (2001). Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood. 98:3554-3561.
69. REILAND, J., FURCHT, L.T. and MCCARTHY, J.B. (1999). CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate. 41:78-88.
70. RETZLAFF, S., PADRO, T., KOCH, P., OELMANN, E., LUGERING, N., MESTERS, R.M. and BERDEL, W.E. (2002). Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma. Oncol. Rep. 9:525-527.
71. RICHMOND, A., BALENTIEN, E., THOMAS, H.G., FLAGGS, G., BARTON, D.E., SPIESS, J., BORDONI, R., FRANCKE, U. and DERYNCK, R. (1988) Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. EMBO J. 7:2025-2033.
72. ROMAGNANI, P., ANNUNZIATO, F., LASAGNI, L., LAZZERI, E., BELTRAME, C., FRANCALANCI, M., UGUCCIONI, M., GALLI, G., COSMI, L., MAURENZIG, L., BAGGIOLINI, M., MAGGI, E., ROMAGNANI, S. and SERIO, M. (2001). Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 107:53-63.
73. RUCKES, T., SAUL, D., VAN SNICK, J., HERMINE, O. and GRASSMANN, R. (2001). Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood 98:1150-1159.
74. SHI, Q., ABBRUZZESE, J.L., HUANG, S., FIDLER, I.J., XIONG, Q. and XIE, K. (1999). Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin. Cancer Res. 5:3711-3721.
75. SINGH, R.K., VARNEY, M.L., BUCANA, C.D. and JOHANSSON, S.L. (1999). Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin. Melanoma Res. 9:383-387.
76. STRIETER, R.M., KUNKEL, S.L., ELNER, V.M., MARTONYI, C.L., KOCH, A.E., POLVERINI, P.J. and ELNER, S.G. (1992). Interleukin-8. A corneal factor that induces neovascularization. Am. J. Pathol. 141:1279-1284.
77. STRIETER, R.M., POLVERINI, P.J., ARENBERG, D.A. and KUNKEL, S.L. (1995a). The role of CXC chemokines as regulators of angiogenesis. Shock. 4:155-160.
78. STRIETER, R.M., POLVERINI, P.J., ARENBERG, D.A., WALZ, A., OPDENAKKER, G., VAN DAMME, J. and KUNKEL, S.L. (1995b). Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J. Leukoc. Biol. 57:752-762.
79. TOSHINA, K., HIRATA, I., MAEMURA, K., SASAKI, S., MURANO, M., NITTA, M., YAMAUCHI, H., NISHIKAWA, T., HAMAMOTO, N. and KATSU, K. (2000). Enprostil, a prostaglandin-E(2) analogue, inhibits interleukin-8 production of human colonic epithelial cell lines. Scand. J. Immunol. 52:570-575.
80. VAN COILLIE, E., VAN AELST, I., WUYTS, A., VERCAUTEREN, R., DEVOS, R., DE WOLF-PEETERS, C., VAN DAMME, J. and OPDENAKKER G. (2001). Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle. Am. J. Pathol. 159:1405-1414.
81. VAN DAMME, J., PROOST, P., LENAERTS, J.-P. and OPDENAKKER, G. (1992). Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med. 176:59-65.
82. VAN DAMME, J., VAN BEEUMEN, J., OPDENAKKER, G. and BILLIAU, A. (1988). A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J. Exp. Med. 167:1364-1376.
83. VAN DEN STEEN, P.E., DUBOIS, B., NELISSEN, I., RUDD, P.M., DWEK, R.A. and OPDENAKKER, G. (2002). Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37:375-536.
84. VAN SNICK, J., HOUSSIAU, F., PROOST, P., VAN DAMME, J. and RENAULD, J.C. (1996). I-309/T cell activation gene-3 chemokine protects murine T cell lymphomas against dexamethasone-induced apoptosis. J. Immunol. 157:2570-2576.
85. VICARI, A.P., AIT-YAHIA, S., CHEMIN, K., MUELLER, A., ZLOTNIK, A. and CAUX, C. (2000). Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms. J. Immunol. 165:1992-2000.
86. WETZEL, K., MENTEN, P., OPDENAKKER, G., VAN DAMME, J., GRONE, H.J., GIESE, N., VECCHI A., SOZZANI S., CORNELIS J.J., ROMMELAERE J. and DINSART C. (2001). Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts. J. Gene Med. 3:326-337.
87. XU, L. and FIDLER, I.J. (2000). Interleukin 8: an autocrine growth factor for human ovarian cancer. Oncol. Res. 12:97-106.
88. YOUNGS, S.J., ALI, S.A., TAUB, D.D. and REES, R.C. (1997). Chemokines induce migrational responses in human breast carcinoma cell lines. Int. J. Cancer. 71:257-266.
89. ZEELENBERG, I.S., RUULS-VAN STALLE, L. and ROOS, E. (2003). The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 63:3833-3839.